Clarithromycin has been evaluated in numerous clinical trials spanning Early Phase through Phase 4 to assess its efficacy in treating *Helicobacter pylori* infections, community-acquired bacterial pneumonia, immune thrombocytopenia, and disseminated *Mycobacterium avium-intracellulare* infections in HIV-positive patients. Supported by academic institutions, government bodies such as the National Institute of Allergy and Infectious Diseases, and pharmaceutical sponsors, these studies encompass completed, actively recruiting, suspended, and withdrawn protocols.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07485010 | NOT_YET_RECRUITING | Mycobacterium Abscessus Pulmonary Disease; Mycobacterium Abscessus Infection; Non-Tuberculous Mycobacterial (NTM) Infections; Non-Tuberculous Mycobacteria Pulmonary Disease |
The University of Queensland |
2027-04 | PHASE2 |
| NCT04415983 | RECRUITING | Helicobacter Pylori Infection |
Tanta University |
2020-06-01 | PHASE3 |
| NCT04310930 | RECRUITING | Pulmonary Disease Due to Mycobacteria (Diagnosis) |
The University of Queensland |
2020-03-02 | PHASE2; PHASE3 |
| NCT07104318 | NOT_YET_RECRUITING | Helicobacter Pylori |
VA Office of Research and Development |
2026-10-01 | PHASE3 |
| NCT03236987 | RECRUITING | Lung Infection; MAC Lung Disease |
Centre Hospitalier Universitaire, Amiens |
2018-02-05 | PHASE3 |
| NCT07341100 | ACTIVE_NOT_RECRUITING | Ovarian Epithelial Cancer |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
2026-01-16 | PHASE2 |
| NCT07115173 | NOT_YET_RECRUITING | Helicobacter Infection |
Samsung Medical Center |
2025-12-01 | PHASE4 |
| NCT02343042 | RECRUITING | Multiple Myeloma |
Karyopharm Therapeutics Inc |
2015-10 | PHASE1; PHASE2 |
| NCT02373280 | RECRUITING | Helicobacter Infection |
Seoul National University Bundang Hospital |
2014-08 | |
| NCT07439445 | RECRUITING | Helicobacter Pylori Infection |
Peking University First Hospital |
2026-04-25 | |
| NCT06349486 | RECRUITING | Helicobacter Pylori Eradication |
Kaohsiung Medical University |
2023-11-28 | |
| NCT06510010 | RECRUITING | Chemotherapy Effect |
Sixth Affiliated Hospital, Sun Yat-sen University |
2024-12-31 | PHASE2 |
| NCT07293910 | RECRUITING | HELICOBACTER PYLORI INFECTIONS; Helicobacter Infection; Helicobacter Pylori Gastrointestinal Tract Infection; Helicobacter Pylori Infected Patients |
Tanta University |
2026-02-15 | PHASE2 |
| NCT06396078 | RECRUITING | Preterm Premature Rupture of Membrane; Pregnancy, High Risk; Preterm Birth |
Ohio State University |
2024-07-18 | PHASE4 |
| NCT05926804 | RECRUITING | Helicobacter Pylori Infection |
Miguel O'Ryan Gallardo |
2022-08-02 | |
| NCT07696091 | NOT_YET_RECRUITING | Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease |
Reistone Biopharma Company Limited |
2026-07 | PHASE1 |
| NCT06200779 | NOT_YET_RECRUITING | Helicobacter Pylori Infection |
Manuel Coelho da Rocha |
2025-09 | PHASE4 |
| NCT07179159 | RECRUITING | HELICOBACTER PYLORI INFECTIONS |
Yanqing Li |
2025-09-09 | |
| NCT05061732 | UNKNOWN | Helicobacter Pylori Infection |
Shanghai Zhongshan Hospital |
2021-09-30 | PHASE4 |
| NCT06964334 | NOT_YET_RECRUITING | Helicobacter Pylori Infection |
Assiut University |
2025-06-01 | PHASE3 |
| NCT05169554 | UNKNOWN | Buruli Ulcer |
Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) |
2021-12-01 | PHASE2 |
| NCT07146594 | NOT_YET_RECRUITING | Helicobacter Pylori Gastritis; Helicobacter Eradication |
Athens Medical Center |
2025-08-20 | PHASE4 |
| NCT07382661 | NOT_YET_RECRUITING | Healthy Adult Volunteers |
Daewon Pharmaceutical Co., Ltd. |
2026-02 | PHASE1 |
| NCT06294600 | RECRUITING | Community-acquired Pneumonia |
Hellenic Institute for the Study of Sepsis |
2024-02-12 | PHASE3 |
| NCT07275827 | NOT_YET_RECRUITING | HELICOBACTER PYLORI INFECTIONS |
Tanta University |
2026-02-01 | PHASE3 |
| NCT06959368 | RECRUITING | Helicobacter Pylori Infection |
Asian Institute of Gastroenterology, India |
2025-03-25 | PHASE4 |
| NCT07514364 | RECRUITING | Mycobacterium Abscessus Lung Disease |
National Taiwan University Hospital |
2026-01-01 | PHASE4 |
| NCT07021729 | NOT_YET_RECRUITING | Helicobacter Pylori Infection |
Rehman Medical Institute - RMI |
2025-12 | PHASE4 |
| NCT07040839 | NOT_YET_RECRUITING | H Pylori |
Rehman Medical Institute - RMI |
2025-07 | PHASE4 |
| NCT06804096 | COMPLETED | Pneumonia, Community-Acquired; Bacterial Pneumonia |
Dr. Md. Alimur Reza |
2025-02-20 | PHASE4 |
| NCT07294846 | COMPLETED | Healthy Volunteers; Patients |
Jiangsu Sinorda Biomedicine Co., Ltd |
2025-09-08 | PHASE1 |
| NCT05495854 | TERMINATED | Helicobacter Pylori Infection |
Poitiers University Hospital |
2023-02-03 | |
| NCT07068607 | RECRUITING | Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer |
Yongquan Shi |
2025-04-01 | PHASE4 |
| NCT05957432 | ACTIVE_NOT_RECRUITING | Helicobacter Pylori Infection |
Ain Shams University |
2023-08-15 | PHASE2 |
| NCT05647278 | COMPLETED | Helicobacter Pylori Infection |
Zhang Xiaofeng,MD |
2023-11-01 | PHASE4 |
| NCT06591494 | NOT_YET_RECRUITING | Helicobacter Pylori Infection |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2024-09-15 | PHASE2; PHASE3 |
| NCT01745588 | COMPLETED | Multiple Myeloma |
Memorial Sloan Kettering Cancer Center |
2012-12 | PHASE2 |
| NCT06004401 | UNKNOWN | The Eradication Rate of Helicobacter Pylori |
Shanghai Changzheng Hospital |
2023-08-20 | |
| NCT07040787 | COMPLETED | Complement Mediated Glomerular Diseases; Hemolytic Anemia |
Chengdu Suncadia Medicine Co., Ltd. |
2025-07-08 | PHASE1 |
| NCT07148622 | COMPLETED | Preterm Premature Rupture of Membranes (PPROM); Prophylaxis; Perinatal Outcomes |
Yuzuncu Yil University |
2024-10-01 | |
| NCT06523764 | ACTIVE_NOT_RECRUITING | Helicobacter Pylori Infection Chronic Gastrit |
Xijing Hospital of Digestive Diseases |
2024-11-11 | PHASE4 |
| NCT02542657 | ACTIVE_NOT_RECRUITING | Myeloma |
Joseph Tuscano |
2015-10 | PHASE1; PHASE2 |
| NCT07086937 | COMPLETED | Helicobacter Pylori Infection |
Muhammad Aamir Latif |
2025-01-01 | |
| NCT04026958 | COMPLETED | Narcolepsy Without Cataplexy; Idiopathic Hypersomnia; Narcolepsy With Cataplexy |
Emory University |
2019-09-04 | PHASE2 |
| NCT06837259 | COMPLETED | Healthy Adults |
Pfizer |
2025-03-19 | PHASE1 |
| NCT07316959 | COMPLETED | Chronic Rhinosinusitis With Nasal Polyps |
Fatima Jinnah Medical University |
2025-01-01 | |
| NCT06514274 | COMPLETED | Helicobacter Pylori Infection; Chronic Gastritis |
Xijing Hospital of Digestive Diseases |
2024-09-20 | PHASE4 |
| NCT06751121 | COMPLETED | Helicobacter Pylori Infection; Helicobacter Pylori Infected Patients; Helicobacter Pylori Infected Subjects |
Daewoong Pharmaceutical Co. LTD. |
2024-02-06 | PHASE3 |
| NCT05191888 | UNKNOWN | Helicobacter Pylori Eradication |
Kaohsiung Medical University |
2021-08-06 | PHASE4 |
| NCT04147065 | UNKNOWN | Helicobacter Pylori Infection |
Incheon St.Mary's Hospital |
2021-07-14 | PHASE4 |
| NCT02387203 | ACTIVE_NOT_RECRUITING | Pseudomyxoma Peritonei; Appendiceal Neoplasms |
Mercy Medical Center |
2015-01 | PHASE2 |
| NCT06318104 | UNKNOWN | Helicobacter Pylori Infection |
Hospital General de México Dr. Eduardo Liceaga |
2024-04-19 | PHASE4 |
| NCT06168214 | UNKNOWN | the Eradication Rates of Helicobacter Pylori |
Xijing Hospital of Digestive Diseases |
2023-09-04 | PHASE4 |
| NCT06156085 | COMPLETED | Helicobacter Pylori Infection |
Fu Jen Catholic University Hospital |
2023-11-14 | PHASE4 |
| NCT04630145 | COMPLETED | Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) |
Janssen Pharmaceutical K.K. |
2021-01-08 | PHASE2; PHASE3 |
| NCT06603688 | UNKNOWN | Helicobacter Pylori Infection; Chronic Gastritis |
Xijing Hospital of Digestive Diseases |
2023-11-20 | PHASE4 |
| NCT06576882 | COMPLETED | Helicobacter Pylori Infection; Gastritis; Vonoprazan; Adolescents |
Alexandria University |
2024-06-30 | PHASE3 |
| NCT06551623 | COMPLETED | Helicobacter Pylori Infection |
TenNor Therapeutics Inc. |
2024-08-26 | PHASE1 |
| NCT02575144 | UNKNOWN | Multiple Myeloma |
PETHEMA Foundation |
2015-09 | PHASE3 |
| NCT06162949 | COMPLETED | Treatment Effectiveness |
Alexandria University |
2024-01-01 | PHASE3 |
| NCT06823791 | COMPLETED | Helicobacter Pylori Infection; Eradication |
Liaocheng People's Hospital |
2022-08-01 | PHASE1; PHASE2 |
| NCT04302324 | ACTIVE_NOT_RECRUITING | Multiple Myeloma; Refractory Multiple Myeloma; Relapse Multiple Myeloma |
Weill Medical College of Cornell University |
2021-10-28 | PHASE2 |
| NCT06250634 | COMPLETED | Helicobacter Pylori Infection |
The Third Xiangya Hospital of Central South University |
2024-02-10 | |
| NCT06414707 | COMPLETED | Helicobacter Pylori Infection |
Ain Shams University |
2023-10-12 | PHASE3 |
| NCT04462133 | WITHDRAWN | Helicobacter Pylori Infection; Antibiotic Resistant Infection |
Incheon St.Mary's Hospital |
2020-09-01 | |
| NCT06227832 | COMPLETED | Healthy Adults |
Kaken Pharmaceutical |
2023-12-15 | PHASE1 |
| NCT05718609 | UNKNOWN | Helicobacter Pylori Infection |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-03-01 | PHASE4 |
| NCT03824847 | SUSPENDED | Influenza, Human |
The University of Hong Kong |
2023-06-01 | PHASE4 |
| NCT05549115 | UNKNOWN | Helicobacter Pylori Infection |
Liaocheng People's Hospital |
2022-09-20 | |
| NCT05857163 | COMPLETED | H.Pylori Infection |
TenNor Therapeutics (Suzhou) Limited |
2023-05-18 | PHASE3 |
| NCT05742568 | COMPLETED | Gastritis; Dyspepsia; Helicobacter Pylori Infection; Gastric Cancer; Peptic Ulcer |
Xijing Hospital of Digestive Diseases |
2022-12-01 | PHASE4 |
| NCT05991401 | COMPLETED | Healthy |
Dong-A ST Co., Ltd. |
2023-08-18 | PHASE1 |
| NCT06005714 | COMPLETED | The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects |
Shanghai Vinnerna Biosciences Co., Ltd. |
2023-08-15 | PHASE1 |
| NCT04658277 | UNKNOWN | Bronchiectasis Adult |
Chinese University of Hong Kong |
2020-10-01 | |
| NCT05965570 | COMPLETED | Healthy Volunteers |
Insmed Incorporated |
2023-07-28 | PHASE1 |
| NCT05419674 | UNKNOWN | Helicobacter Pylori Infection |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-08-01 | PHASE4 |
| NCT05716854 | COMPLETED | Drug-induced QT Prolongation; Pharmacokinetics; Pharmacodynamics |
Food and Drug Administration (FDA) |
2023-03-21 | PHASE1 |
| NCT04901117 | UNKNOWN | Helicobacter Pylori Infection |
Shandong University |
2021-06 | PHASE4 |
| NCT04652284 | UNKNOWN | Helicobacter Infections; Resistance Bacterial; Gastritis H Pylori |
Rabin Medical Center |
2021-05-01 | PHASE3 |
| NCT04359966 | UNKNOWN | Helicobacter Pylori Infection; Eradication Treatments |
Slovenian Society for Gastroenterology and Hepatology |
2020-05-10 | |
| NCT05633147 | COMPLETED | Safety Issues; Pharmacokinetics; Drug Interaction; Tolerability |
Cinclus Pharma Holding AB |
2022-11-27 | PHASE1 |
| NCT05049902 | COMPLETED | Helicobacter Pylori Infection |
Shandong University |
2021-09-21 | PHASE4 |
| NCT05614934 | COMPLETED | Helicobacter Pylori Infection |
Alexandria University |
2022-06-11 | PHASE4 |
| NCT05915871 | COMPLETED | Healthy |
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. |
2023-03-23 | PHASE1 |
| NCT04724044 | COMPLETED | Community-acquired Pneumonia; Sepsis; Inflammatory Response; Mortality; Biomarkers; SIRS |
Hellenic Institute for the Study of Sepsis |
2021-01-25 | PHASE3 |
| NCT05345210 | UNKNOWN | Helicobacter Pylori |
Xijing Hospital of Digestive Diseases |
2022-04-25 | PHASE4 |
| NCT04287660 | UNKNOWN | Multiple Myeloma |
The First Affiliated Hospital of Soochow University |
2017-10-19 | PHASE3 |
| NCT05189444 | UNKNOWN | Helicobacter Pylori Infection |
Huazhong University of Science and Technology |
2022-03-25 | |
| NCT05196945 | UNKNOWN | Helicobacter Pylori Eradication Rate |
Sixth Affiliated Hospital, Sun Yat-sen University |
2022-03-31 | PHASE4 |
| NCT05023577 | UNKNOWN | Helicobacter Pylori Infection |
Shanghai Zhongshan Hospital |
2021-08-26 | PHASE4 |
| NCT05250050 | WITHDRAWN | Helicobacter Pylori Infection |
Shanghai Zhongshan Hospital |
2022-03-25 | PHASE4 |
| NCT05410223 | UNKNOWN | Helicobacter Pylori Infection |
The Third Xiangya Hospital of Central South University |
2021-04-06 | |
| NCT04843579 | TERMINATED | Myeloma Multiple; Myeloma; Refractory Multiple Myeloma |
Weill Medical College of Cornell University |
2021-12-29 | PHASE2 |
| NCT05469126 | COMPLETED | Healthy |
Eli Lilly and Company |
2022-08-01 | PHASE1 |
| NCT05664685 | Completed | Helicobacter Pylori Infection |
Pontificia Universidad Catolica de Chile |
2022-10-17 | Phase 4 |
| NCT04721704 | UNKNOWN | H Pylori Gastritis |
Shaheed Zulfiqar Ali Bhutto Medical University |
2020-09-14 | |
| NCT04853875 | COMPLETED | Helicobacter Pylori Infection |
Mackay Memorial Hospital |
2021-04-19 | PHASE4 |
| NCT05126121 | UNKNOWN | Helicobacter Pylori Infection |
Xiuli Zuo |
2021-11-20 | |
| NCT02516696 | TERMINATED | Multiple Myeloma |
Weill Medical College of Cornell University |
2016-02 | PHASE3 |
| NCT04558502 | UNKNOWN | Helicobacter Pylori Eradication |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-01-05 | PHASE4 |
| NCT05845567 | COMPLETED | Drug Drug Interaction |
Italfarmaco |
2022-03-21 | PHASE1 |
| NCT05014334 | COMPLETED | Helicobacter Pylori Infection; Chronic Gastritis |
Xijing Hospital of Digestive Diseases |
2021-12-01 | PHASE4 |
| NCT05259007 | UNKNOWN | Helicobacter Pylori Infection |
Fatma Zehra Arvas |
2022-02-22 | PHASE4 |
| NCT04551963 | COMPLETED | B-cell Malignancies |
BeiGene |
2020-11-15 | PHASE1 |
| NCT05342532 | COMPLETED | Helicobacter Pylori Infection |
Icahn School of Medicine at Mount Sinai |
2019-06-12 | PHASE4 |
| NCT03021590 | WITHDRAWN | Helicobacter Pylori Gastrointestinal Tract Infection |
Damascus Hospital |
2017-06-01 | PHASE4 |
| NCT05137600 | COMPLETED | Drug Drug Interaction |
Antios Therapeutics, Inc |
2021-10-28 | PHASE1 |
| NCT04697186 | COMPLETED | Dyspepsia; Chronic Gastritis; Gastric Cancer; Helicobacter Pylori Infection |
Xijing Hospital of Digestive Diseases |
2021-01-07 | PHASE4 |
| NCT03440112 | COMPLETED | Parkinson Disease |
Nicolaas Bohnen, MD, PhD |
2018-01-29 | PHASE1; PHASE2 |
| NCT05861687 | COMPLETED | Helicobacter Pylori Infection |
Finni Kollins |
2021-08-01 | PHASE2; PHASE3 |
| NCT05417997 | COMPLETED | COVID-19 Respiratory Infection; FLU; Cold; Influenza; Bacterial Pneumonia; COVID-19 Pneumonia |
RAAS Nutritionals, LLC |
2021-05-29 | PHASE3 |
| NCT04198363 | COMPLETED | Helicobacter Pylori |
Takeda |
2020-04-30 | PHASE3 |
| NCT04449185 | UNKNOWN | Dyspepsia |
Asan Medical Center |
2020-06-30 | PHASE4 |
| NCT03173053 | TERMINATED | Staphylococcus Aureus; Motility Disorder |
Radboud University Medical Center |
2018-02-08 | |
| NCT05035186 | COMPLETED | Helicobacter Pylori Infection |
Alexandria University |
2021-03-21 | |
| NCT04753437 | COMPLETED | Helicobacter Pylori |
Takeda |
2021-04-06 | PHASE1 |
| NCT04101708 | UNKNOWN | Helicobacter Pylori |
Shandong University |
2019-09-20 | PHASE4 |
| NCT03555526 | UNKNOWN | H Pylori Infection |
National Taiwan University Hospital |
2017-12-15 | PHASE4 |
| NCT04951713 | UNKNOWN | Healthy |
Xuanzhu Biopharmaceutical Co., Ltd. |
2021-07 | PHASE1 |
| NCT04901663 | COMPLETED | Helicobacter Pylori Infection |
Dow University of Health Sciences |
2021-06-21 | PHASE4 |
| NCT06315478 | COMPLETED | H.Pylori Infection |
Helwan University |
2021-02-01 | PHASE4 |
| NCT04167670 | COMPLETED | Helicobacter Pylori Infection |
Phathom Pharmaceuticals, Inc. |
2019-12-10 | PHASE3 |
| NCT04107194 | UNKNOWN | Helicobacter Pylori Infection; Antibiotic Resistant Infection; Antibiotic Resistant Strain |
University of Bari |
2020-01-14 | PHASE3 |
| NCT05194046 | COMPLETED | Helicobacter Pylori Associated Gastrointestinal Disease |
Onconic Therapeutics Inc. |
2020-11-18 | PHASE1 |
| NCT04128917 | COMPLETED | Helicobacter Pylori Infection |
HK inno.N Corporation |
2020-01-21 | PHASE3 |
| NCT07211880 | COMPLETED | H.Pylori; Gastric Cancer; H Pylori Eradication |
Zero Helicobacter IGAN Network |
2019-12-05 | |
| NCT05237115 | COMPLETED | Gastritis; Peptic Ulcer; Dyspepsia |
Xijing Hospital of Digestive Diseases |
2020-05-05 | PHASE4 |
| NCT02019875 | COMPLETED | Vitamin D and Calcium Homeostasis |
University of Washington |
2014-06 | EARLY_PHASE1 |
| NCT01503606 | COMPLETED | Preterm Premature Rupture of Membrane |
Samsung Medical Center |
2011-10 | PHASE3 |
| NCT04398004 | COMPLETED | COVID-19; Virus Diseases; Corona Virus Infection |
Hellenic Institute for the Study of Sepsis |
2020-05-06 | PHASE2 |
| NCT03431688 | COMPLETED | Helicobacter Pylori Infection |
Kangdong Sacred Heart Hospital |
2018-10-01 | |
| NCT03592069 | COMPLETED | H.Pylori Infection; H.Pylori Gastrointestinal Disease; H. Pylori Associated Phlegmonous Gastritis |
Alexandra Hospital, Athens, Greece |
2018-02-21 | PHASE4 |
| NCT04444011 | UNKNOWN | Healthy Male Volunteers |
Sihuan Pharmaceutical Holdings Group Ltd. |
2020-07-01 | PHASE1 |
| NCT03238612 | UNKNOWN | Influenza A |
The University of Hong Kong |
2018-01-08 | PHASE2 |
| NCT04622891 | COMPLETED | Covid19 |
South Valley University |
2020-04-01 | |
| NCT04445948 | COMPLETED | Helicobacter Pylori Infection |
Alexandria University |
2019-11-30 | PHASE4 |
| NCT03688828 | COMPLETED | Helicobacter Pylori Infection |
Huazhong University of Science and Technology |
2018-11-11 | |
| NCT03566004 | COMPLETED | Helicobacter Pylori |
Poitiers University Hospital |
2015-12-10 | |
| NCT03172676 | UNKNOWN | Immune Thrombocytopenia |
Assiut University |
2020-01-01 | PHASE4 |
| NCT04090021 | UNKNOWN | Helicobacter Pylori Infection |
Konstantopoulio-Patission General Hospital of Nea Ionia |
2019-09-01 | PHASE4 |
| NCT04063189 | UNKNOWN | Multiple Myeloma in Relapse |
The First Hospital of Jilin University |
2017-03-21 | PHASE2 |
| NCT04621487 | COMPLETED | Helicobacter Pylori Infection |
University of Split, School of Medicine |
2019-01-15 | |
| NCT03498456 | COMPLETED | Helicobacter Pylori Infection |
HK inno.N Corporation |
2018-06-28 | PHASE3 |
| NCT03208426 | UNKNOWN | Helicobacter Pylori Infection |
National Taiwan University Hospital |
2017-10-01 | PHASE4 |
| NCT03658746 | COMPLETED | Helicobacter Pylori Infection |
Shandong University |
2019-01-01 | PHASE4 |
| NCT03571230 | UNKNOWN | Helicobacter Pylori Infection; Antimicrobial Susceptibility Testing |
Shandong University |
2018-07-01 | PHASE4 |
| NCT02923856 | UNKNOWN | Gastritis |
Sanmen People's Hospital |
2017-01 | |
| NCT04070495 | COMPLETED | Parkinson's Disease |
Kyowa Kirin Co., Ltd. |
2019-08-27 | PHASE1 |
| NCT03031483 | COMPLETED | Mucosa Associated Lymphoid Tissue (MALT) Lymphoma |
International Extranodal Lymphoma Study Group (IELSG) |
2017-04-03 | PHASE2 |
| NCT03708848 | COMPLETED | Helicobacter Pylori Infection |
Shanghai Jiao Tong University School of Medicine |
2018-12-05 | PHASE4 |
| NCT03345992 | COMPLETED | Sepsis; Pneumonia; Gram-Negative Bacteria Infection; Multiple Organ Failure; Respiratory Distress Syndrome; Mortality; Biomarkers |
Hellenic Institute for the Study of Sepsis |
2017-12-15 | PHASE3 |
| NCT03709355 | COMPLETED | HIV-1-infection |
Viriom |
2018-11-14 | PHASE1 |
| NCT02248428 | UNKNOWN | Multiple Myeloma |
Jinling Hospital, China |
2012-04 | PHASE3 |
| NCT03716622 | COMPLETED | Helicobacter Pylori |
Shandong University |
2018-07-31 | PHASE4 |
| NCT03043989 | TERMINATED | Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2017-03-21 | PHASE1 |
| NCT02852083 | UNKNOWN | Squamous Cell Lung Cancer; Non-Squamous Cell Lung Cancer; Non-Small Cell Lung Cancer |
University Hospital Regensburg |
2016-01 | PHASE2 |
| NCT03800550 | COMPLETED | Healthy |
Janssen Research & Development, LLC |
2019-02-13 | PHASE1 |
| NCT04061447 | COMPLETED | Helicobacter Pylori Infection |
Kaohsiung Medical University |
2016-02-05 | |
| NCT04697641 | COMPLETED | Dyspepsia; Helicobacter Pylori Infection |
Sir Ganga Ram Hospital |
2017-09-01 | |
| NCT04525664 | COMPLETED | Helicobacter Pylori Infection; Dyspepsia |
Washington University School of Medicine |
2018-10-01 | EARLY_PHASE1 |
| NCT03065868 | COMPLETED | Gastric Polyp; Helicobacter Pylori Infection |
Kyungpook National University Hospital |
2015-12-09 | PHASE4 |
| NCT03829150 | COMPLETED | Helicobacter Pylori Infection |
Chang Gung Memorial Hospital |
2017-03-01 | |
| NCT01298336 | COMPLETED | Atypical; Mycobacterium, Pulmonary, Tuberculous |
Centre Hospitalier Universitaire, Amiens |
2011-03-02 | PHASE3 |
| NCT03428568 | UNKNOWN | Acid Dyspepsia; Gastritis |
King Abdullah International Medical Research Center |
2018-03 | PHASE2 |
| NCT02576236 | UNKNOWN | H Pylori Infection Eradication; Antibiotics Therapeutic Strategies; H Pylori Eradication |
Assistance Publique - Hôpitaux de Paris |
2016-05 | |
| NCT03130452 | COMPLETED | Helicobacter Pylori Infection |
Inje University |
2016-12-17 | PHASE4 |
| NCT03317223 | COMPLETED | Helicobacter Pylori Infection |
HK inno.N Corporation |
2017-10-17 | PHASE3 |
| NCT03487562 | COMPLETED | Healthy |
Daewoong Pharmaceutical Co. LTD. |
2018-04-08 | PHASE1 |
| NCT03414918 | UNKNOWN | Hyperaldosteronism |
University Hospital Padova |
2018-03 | |
| NCT03220542 | UNKNOWN | Helicobacter Pylori Infection |
Kyunghee University Medical Center |
2016-01 | PHASE4 |
| NCT02827942 | COMPLETED | Gastritis Associated With Helicobacter Pylori |
Hamamatsu University |
2016-07-01 | PHASE3 |
| NCT04132479 | COMPLETED | Helicobacter Pylori Infection |
Kirby Institute |
2018-01-01 | PHASE4 |
| NCT03516669 | COMPLETED | Helicobacter Pylori Infection |
Mackay Memorial Hospital |
2018-05-07 | PHASE4 |
| NCT02986451 | WITHDRAWN | Relapse/Refractory Multiple Myeloma |
Sun Yat-sen University |
2016-12 | PHASE2 |
| NCT02557932 | COMPLETED | Helicobacter Pylori Infection; Family History of Stomach Cancer |
National Cancer Center, Korea |
2015-09 | PHASE3 |
| NCT02422706 | UNKNOWN | Helicobacter-associated Gastritis |
Sherief Abd-Elsalam |
2015-01 | PHASE3 |
| NCT05380245 | COMPLETED | Healthy |
Abdul Wali Khan University Mardan |
2018-11-01 | PHASE4 |
| NCT03009396 | COMPLETED | Crohn Disease |
RedHill Biopharma Limited |
2017-03-18 | PHASE3 |
| NCT04617613 | COMPLETED | Helicobacter Pylori Infection |
Al-Azhar University |
2016-09 | PHASE4 |
| NCT03413020 | COMPLETED | Helicobacter Pylori Infection |
Shanghai Jiao Tong University School of Medicine |
2018-01-03 | PHASE4 |
| NCT03361267 | UNKNOWN | Helicobacter Pylori Infection; Compliance, Patient; Drug Resistance; Antibiotics |
Inha University Hospital |
2017-12-30 | |
| NCT02741414 | UNKNOWN | Gastritis |
Taizhou Hospital |
2016-06 | |
| NCT02935010 | COMPLETED | Helicobacter Pylori Infection |
Shanghai Jiao Tong University School of Medicine |
2017-02-05 | PHASE4 |
| NCT02761005 | UNKNOWN | H. Pylori Infection |
Hamamatsu University |
2016-05 | PHASE2 |
| NCT03366974 | COMPLETED | Healthy Volunteers |
Seoul National University Hospital |
2017-12-28 | PHASE1 |
| NCT02776371 | COMPLETED | Helicobacter Pylori Eradication Rate |
Shandong University |
2016-09 | PHASE4 |
| NCT03124420 | COMPLETED | Helicobacter Pylori Infection |
Mackay Memorial Hospital |
2017-04-28 | PHASE4 |
| NCT02959255 | COMPLETED | Helicobacter Pylori Infection |
Elpen Pharmaceutical Co. Inc. |
2017-01-30 | PHASE4 |
| NCT03142620 | UNKNOWN | H. Pylori Infection |
Chinese University of Hong Kong |
2015-03 | PHASE3 |
| NCT01659437 | COMPLETED | Mycobacterium Ulcerans Infection |
University Medical Center Groningen |
2012-12 | PHASE2; PHASE3 |
| NCT01906879 | UNKNOWN | Helicobacter Pylori Infection |
National Taiwan University Hospital |
2013-06 | PHASE4 |
| NCT02388581 | UNKNOWN | Gastric Diffuse Large B-cell Lymphoma |
National Health Research Institutes, Taiwan |
2014-12 | PHASE2 |
| NCT01506986 | COMPLETED | Gastrointestinal Ulcer Haemorrhage; Bacterial Infection Due to Helicobacter Pylori (H. Pylori) |
University of Nottingham |
2012-03 | PHASE4 |
| NCT02732249 | COMPLETED | Helicobacter Pylori Infection |
Shanghai Jiao Tong University School of Medicine |
2016-04-01 | PHASE4 |
| NCT02988089 | UNKNOWN | Helicobacter Pylori Infection; Antimicrobial Susceptibility Testing |
Shandong University |
2017-04-20 | PHASE4 |
| NCT03139253 | UNKNOWN | Antimicrobial Susceptibility Testing; Triple Therapy |
Yanqing Li |
2017-05-30 | PHASE4 |
| NCT03134378 | UNKNOWN | Helicobacter Pylori Infection |
Indonesia University |
2016-10-03 | PHASE4 |
| NCT00445692 | COMPLETED | DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
Fred Hutchinson Cancer Center |
2007-01-10 | PHASE2 |
| NCT02892409 | COMPLETED | Helicobacter Pylori |
Takeda |
2016-09-05 | PHASE1 |
| NCT02975037 | COMPLETED | Healthy |
Seoul National University Hospital |
2017-02-06 | PHASE1 |
| NCT03011463 | COMPLETED | Pharmacokinetics; Inhibition Enzyme; Drug Interaction Potentiation |
Dr. R. Pfleger Chemische Fabrik GmbH |
2016-11 | PHASE1 |
| NCT03011996 | COMPLETED | Drug Interaction; Pharmacokinetic; Pharmacodynamic |
HK inno.N Corporation |
2016-05 | PHASE1 |
| NCT02693574 | UNKNOWN | Helicobacter Pylori Gastrointestinal Tract Infection |
Damascus Hospital |
2015-12-01 | PHASE4 |
| NCT02648659 | COMPLETED | Peptic Ulcer |
Kyungpook National University Hospital |
2016-03-02 | PHASE4 |
| NCT02998437 | COMPLETED | Drug Interaction Potentiation |
Il-Yang Pharm. Co., Ltd. |
2016-12 | PHASE1 |
| NCT02969928 | COMPLETED | Aggressive Periodontitis |
Universidade Estadual Paulista Júlio de Mesquita Filho |
2015-03 | PHASE2; PHASE3 |
| NCT03132714 | COMPLETED | Aggressive Periodontitis, Generalized |
Universidade Estadual Paulista Júlio de Mesquita Filho |
2015-03 | PHASE2; PHASE3 |
| NCT02912234 | COMPLETED | Venous Thromboembolism |
Bristol-Myers Squibb |
2016-09 | PHASE1 |
| NCT02466919 | COMPLETED | Helicobacter Pylori Infection |
Chung-Tai Wu |
2014-05 | PHASE4 |
| NCT02361619 | COMPLETED | Healthy Volunteers |
Turku University Hospital |
2015-02 | PHASE1 |
| NCT02573935 | TERMINATED | Multiple Myeloma |
Henrik Gregersen |
2015-01 | PHASE2 |
| NCT02249546 | UNKNOWN | Helicobacter Pylori Infection |
National Taiwan University Hospital |
2014-09 | PHASE4 |
| NCT02624440 | UNKNOWN | Multiple Myeloma; Infection |
Henrik Gregersen |
2013-01 | PHASE2 |
| NCT01559935 | COMPLETED | Multiple Myeloma |
Weill Medical College of Cornell University |
2012-04-19 | PHASE2 |
| NCT02633930 | COMPLETED | Gastritis; Peptic Ulcer; Dyspepsia |
Xijing Hospital of Digestive Diseases |
2015-12 | PHASE4 |
| NCT02407119 | ACTIVE_NOT_RECRUITING | Helicobacter Pylori Infection; Early Gastric Cancer; Endoscopic Resection |
National Cancer Center, Korea |
2003-06 | PHASE3 |
| NCT02182492 | COMPLETED | Chronic Rhinosinusitis; Endoscopic Sinus Surgery |
Zheng Liu |
2014-01 | |
| NCT00327132 | COMPLETED | Gastric MALT Lymphoma |
National Health Research Institutes, Taiwan |
2006-07 | |
| NCT02416570 | TERMINATED | Cachexia; Lung Cancer |
University of Nottingham |
2015-04 | PHASE2 |
| NCT02296021 | COMPLETED | Gastritis; Peptic Ulcer; Dyspepsia |
Xijing Hospital of Digestive Diseases |
2014-11 | PHASE4 |
| NCT03650543 | COMPLETED | CYP2C19 Polymorphism; H.Pylori Infection; Therapy |
Javeriana University |
2012-09-10 | PHASE4 |
| NCT03142776 | COMPLETED | Aggressive Periodontitis, Generalized |
Universidade Estadual Paulista Júlio de Mesquita Filho |
2014-03 | |
| NCT02829983 | COMPLETED | Aggressive Periodontitis |
Universidade Estadual Paulista Júlio de Mesquita Filho |
2014-03 | |
| NCT01159574 | COMPLETED | Multiple Myeloma |
Weill Medical College of Cornell University |
2010-08 | PHASE2 |
| NCT02159976 | COMPLETED | Helicobacter Pylori Infection |
Seoul National University Bundang Hospital |
2014-07 | |
| NCT01454076 | COMPLETED | Nonhematologic Malignancies; Lymphoma |
Millennium Pharmaceuticals, Inc. |
2011-11-10 | PHASE1 |
| NCT03362281 | COMPLETED | Peptic Ulcer Hemorrhage |
Livzon Pharmaceutical Group Inc. |
2014-10 | PHASE3 |
| NCT02343289 | COMPLETED | Healthy |
Janssen Research & Development, LLC |
2015-01 | PHASE1 |
| NCT03124199 | COMPLETED | Bacterial Infection Due to Helicobacter Pylori (H. Pylori) |
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
2014-02 | PHASE3 |
| NCT02117648 | COMPLETED | Neoplasm; Neoplasm Metastasis |
Eli Lilly and Company |
2014-04 | PHASE1 |
| NCT01279252 | COMPLETED | Chronic Lymphocytic Leukaemia (CLL) |
King's College Hospital NHS Trust |
2011-07 | PHASE2 |
| NCT02175901 | COMPLETED | Dyspepsia; Peptic Ulcer |
Shanghai Jiao Tong University School of Medicine |
2014-07 | PHASE4 |
| NCT02286635 | COMPLETED | Healthy Volunteers |
PTC Therapeutics |
2014-11 | PHASE1 |
| NCT01481844 | COMPLETED | Optimization of Second Line Treatment Protocol for H Pylori Eradication |
Soroka University Medical Center |
2011-11 | PHASE3 |
| NCT01289756 | COMPLETED | Anovulation; Disorder Due Cytochrome P450 CYP2D6 Variant; Cytochrome P450 CYP3A Enzyme Deficiency |
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) |
2009-12 | PHASE1 |
| NCT02807051 | COMPLETED | Drug Interaction Study |
CTI BioPharma |
2014-09 | PHASE1 |
| NCT02197884 | COMPLETED | Healthy |
Janssen Research & Development, LLC |
2014-07 | PHASE1 |
| NCT02275988 | COMPLETED | Healthy |
Kowa Research Institute, Inc. |
2014-06 | PHASE1 |
| NCT00914888 | WITHDRAWN | Community Acquired Bacterial Pneumonia; Complicated Intra-Abdominal Infection |
Wyeth is now a wholly owned subsidiary of Pfizer |
2011-01 | PHASE3 |
| NCT01602874 | WITHDRAWN | Community Acquired Bacterial Pneumonia; Complicated Intra-Abdominal Infection |
Pfizer |
2011-01 | PHASE3 |
| NCT01851954 | TERMINATED | Very Low Birth Weight Infant; Ureaplasma/Mycoplasma Positive |
Seoul National University Hospital |
2013-02 | PHASE2 |
| NCT02726269 | COMPLETED | Helicobacter Pylori Gastritis |
Asofarma de México S.A de C.V. |
2012-06 | PHASE3 |
| NCT01922765 | UNKNOWN | Gastritis, Gastric Ulcer, and Duodenal Ulcer |
The Catholic University of Korea |
2013-08 | PHASE4 |
| NCT01374217 | TERMINATED | Multiple Myeloma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2012-04 | PHASE2 |
| NCT02052336 | COMPLETED | Healthy |
HK inno.N Corporation |
2013-10 | PHASE1 |
| NCT01516606 | COMPLETED | Lymphoma |
Andres J. M. Ferreri |
2012-01 | PHASE2 |
| NCT01607918 | UNKNOWN | Eradication Rates of the Two Regimens |
National Taiwan University Hospital |
2012-02 | PHASE4 |
| NCT01921647 | COMPLETED | Healthy |
Yuhan Corporation |
2013-07 | PHASE1 |
| NCT01836198 | COMPLETED | Healthy Volunteers |
Eli Lilly and Company |
2013-05 | PHASE1 |
| NCT02080780 | COMPLETED | CLARITHROMYCIN/DILTIAZEM [VA Drug Interaction] |
Ventrus Biosciences, Inc |
2013-09 | PHASE1 |
| NCT01207739 | COMPLETED | Lyme Disease; Borrelia Infection |
Radboud University Medical Center |
2010-09 | PHASE4 |
| NCT05340452 | COMPLETED | Healthy |
University of Karachi |
2013-06-29 | |
| NCT01887249 | COMPLETED | Helicobacter Pylori Infection |
Seoul National University Bundang Hospital |
2010-05 | PHASE4 |
| NCT01163435 | COMPLETED | Helicobacter Infection |
National Taiwan University Hospital |
2010-08 | PHASE4 |
| NCT01505127 | COMPLETED | H. Pylori Infection |
Takeda |
2012-01 | PHASE3 |
| NCT02922699 | COMPLETED | GERD |
Dr. Reddy's Laboratories Limited |
2013-01 | PHASE4 |
| NCT01667575 | COMPLETED | Functional Dyspepsia; Peptic Ulcer; Helicobacter Pylori |
Shanghai Jiao Tong University School of Medicine |
2012-08 | PHASE4 |
| NCT01219764 | COMPLETED | Helicobacter Infections |
American University of Beirut Medical Center |
2010-10 | PHASE4 |
| NCT02359721 | COMPLETED | Periodontitis |
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre |
2012-01 | PHASE4 |
| NCT00818610 | COMPLETED | Community-acquired Pneumonia |
Swiss National Fund for Scientific Research |
2009-01 | PHASE4 |
| NCT01593592 | COMPLETED | Helicobacter Pylori Infection |
Zagazig University |
2012-06 | |
| NCT01464060 | UNKNOWN | Helicobacter Pylori Infection |
Infante, Javier Molina, M.D. |
2011-09 | PHASE4 |
| NCT01652118 | UNKNOWN | Bronchopulmonary Dysplasia |
Zekai Tahir Burak Women's Health Research and Education Hospital |
2011-10 | PHASE3 |
| NCT05436769 | COMPLETED | Healthy Volunteers; Bioequivalence Study |
University of Karachi |
2012-10-23 | PHASE1 |
| NCT01521364 | COMPLETED | Multidrug-resistant Tuberculosis; Extensively Drug-resistant Tuberculosis |
University Medical Center Groningen |
2011-12 | PHASE4 |
| NCT01146600 | COMPLETED | Hypersomnia; Idiopathic Hypersomnia; Narcolepsy |
Lynn Marie Trotti |
2010-07 | PHASE2 |
| NCT01453036 | COMPLETED | Peptic Ulcer; Helicobacter Pylori Infection |
Jin Il Kim |
2011-08 | PHASE4 |
| NCT03165253 | COMPLETED | Helicobacter Pylori Infection |
Bulent Ecevit University |
2011-06 | |
| NCT01273441 | COMPLETED | Helicobacter Pylori |
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
2010-12 | PHASE4 |
| NCT01168063 | COMPLETED | Helicobacter Pylori Infection |
Assistance Publique - Hôpitaux de Paris |
2010-02 | |
| NCT01385683 | COMPLETED | Healthy |
Centre Hospitalier Universitaire de Saint Etienne |
2011-06 | PHASE1 |
| NCT01460407 | COMPLETED | Depressive Disorder, Major |
Eli Lilly and Company |
2011-10 | PHASE1 |
| NCT01667692 | COMPLETED | Peptic Ulcer; Dyspepsia; H-pylori |
Shahid Sadoughi University of Medical Sciences and Health Services |
2011-03 | PHASE4 |
| NCT01223690 | COMPLETED | Sepsis; Severe Sepsis; Septic Shock |
University of Athens |
2007-07 | PHASE3 |
| NCT01306786 | COMPLETED | Helicobacter Pylori Infection |
The University of Hong Kong |
2008-11 | |
| NCT00990405 | UNKNOWN | Functional Dyspepsia; Helicobacter Pylori Infection |
Korean College of Helicobacter and Upper Gastrointestinal Research |
2009-10 | PHASE4 |
| NCT02774902 | COMPLETED | Healthy Volunteers |
Takeda |
2010-08 | PHASE1 |
| NCT01326611 | COMPLETED | Chronic Lung Disease |
Zekai Tahir Burak Women's Health Research and Education Hospital |
2008-05 | PHASE4 |
| NCT00538733 | COMPLETED | Multiple Myeloma |
Weill Medical College of Cornell University |
2007-10 | PHASE2 |
| NCT01401179 | COMPLETED | Preterm Premature Rupture of the Membranes |
Samsung Medical Center |
2005-04 | PHASE3 |
| NCT01575899 | TERMINATED | Helicobacter Pylori Infection |
Buddhist Tzu Chi General Hospital |
2007-12 | PHASE4 |
| NCT00816140 | COMPLETED | Helicobacter Infections |
National Taiwan University Hospital |
2007-06 | PHASE4 |
| NCT01421706 | COMPLETED | Healthy |
Inje University |
2008-07 | PHASE1 |
| NCT00669955 | COMPLETED | Helicobacter Infections |
Forest Laboratories |
2008-06 | PHASE3 |
| NCT00717561 | COMPLETED | Pneumonia |
Bayer |
2008-02 | PHASE3 |
| NCT00318708 | COMPLETED | Asthma |
Milton S. Hershey Medical Center |
2006-06 | PHASE3 |
| NCT00772837 | COMPLETED | Functional Dyspepsia; Helicobacter Pylori Infection |
Aga Khan University |
2006-08 | |
| NCT00983034 | COMPLETED | Nephrotic Syndrome; Glomerulonephritis; Membranous Nephropathy |
Istanbul University |
2006-03 | |
| NCT00621504 | COMPLETED | Bacterial Pneumonia |
Forest Laboratories |
2008-01 | PHASE3 |
| NCT00355602 | COMPLETED | Colitis, Ulcerative |
University of Dundee |
2006-07 | |
| NCT00467571 | COMPLETED | Chronic Idiopathic Thrombocytopenic Purpura; Helicobacter Pylori Infection |
Mahidol University |
2006-03 | PHASE4 |
| NCT02171585 | COMPLETED | Healthy |
Boehringer Ingelheim |
2008-06 | PHASE1 |
| NCT00707330 | COMPLETED | Oxidative Stress |
Rigshospitalet, Denmark |
2008-05 | PHASE1 |
| NCT00321178 | COMPLETED | Buruli Ulcer; Mycobacterium Ulcerans |
University Medical Center Groningen |
2006-05 | PHASE2; PHASE3 |
| NCT00984061 | COMPLETED | Pharmacokinetics |
Mutual Pharmaceutical Company, Inc. |
2007-11 | PHASE1 |
| NCT00336505 | COMPLETED | Pneumonia |
Advanced Life Sciences, Inc. |
2005-12 | PHASE3 |
| NCT00513552 | WITHDRAWN | Crohn's Disease |
Medstar Health Research Institute |
2007-07 | PHASE4 |
| NCT00336544 | COMPLETED | Pneumonia |
Advanced Life Sciences, Inc. |
2006-06 | PHASE3 |
| NCT00151203 | COMPLETED | Multiple Myeloma |
Weill Medical College of Cornell University |
2004-12 | PHASE2 |
| NCT00182663 | COMPLETED | Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma |
Fred Hutchinson Cancer Center |
2003-06 | PHASE2 |
| NCT00719420 | COMPLETED | Helicobacter Pylori Infection |
University of North Texas Health Science Center |
2006-04 | PHASE3 |
| NCT00269386 | COMPLETED | Crohn's Disease |
Royal Liverpool University Hospital |
2000-04 | PHASE3 |
| NCT00006219 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Mayo Clinic |
2000-08 | PHASE2 |
| NCT00600769 | COMPLETED | Nontuberculous Mycobacteria; Mycobacterium Avium Complex |
The University of Texas Health Science Center at Tyler |
1991-01 | PHASE4 |
| NCT00775372 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2005-09 | |
| NCT00775255 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2005-09 | |
| NCT04016051 | COMPLETED | Otitis Media; Tonsillitis; Pharyngitis; Bronchitis |
Grünenthal GmbH |
2004-09-22 | PHASE3 |
| NCT00205634 | COMPLETED | Cystic Fibrosis |
Wake Forest University |
2000-12 | PHASE2 |
| NCT00648830 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2004-05 | PHASE1 |
| NCT00645086 | COMPLETED | Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). |
Abbott |
2002-12 | PHASE3 |
| NCT00644553 | COMPLETED | Acute Bacterial Sinusitis (ABS) |
Abbott |
2003-05 | PHASE3 |
| NCT00201422 | COMPLETED | MALT Lymphoma |
National Health Research Institutes, Taiwan |
1996-06 | |
| NCT02251769 | COMPLETED | Healthy |
Boehringer Ingelheim |
2003-08 | PHASE1 |
| NCT00774189 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2003-07 | PHASE1 |
| NCT00648960 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2003-07 | PHASE1 |
| NCT00601315 | COMPLETED | Infection |
Roxane Laboratories |
2003-04 | |
| NCT00648128 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2003-03 | PHASE1 |
| NCT00602498 | COMPLETED | Infection |
Roxane Laboratories |
2003-03 | |
| NCT00774644 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2002-12 | |
| NCT00774696 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2002-12 | |
| NCT00840411 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-09 | PHASE1 |
| NCT00835692 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-09 | PHASE1 |
| NCT00598897 | COMPLETED | Mycobacterium Avium Complex Lung Disease |
The University of Texas Health Science Center at Tyler |
1995-08 | PHASE4 |
| NCT00840216 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-08 | PHASE1 |
| NCT00836706 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-07 | PHASE1 |
| NCT00881179 | COMPLETED | Healthy |
Sandoz |
2002-05 | PHASE1 |
| NCT00881738 | COMPLETED | Healthy |
Sandoz |
2002-06 | PHASE1 |
| NCT00002682 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1995-08-10 | PHASE2 |
| NCT00121550 | COMPLETED | Heart Disease; Cardiovascular Disease |
Copenhagen Trial Unit, Center for Clinical Intervention Research |
1999-10 | PHASE3 |
| NCT00003151 | COMPLETED | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1997-09 | PHASE2 |
| NCT00000644 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00002331 | COMPLETED | Mycobacterium Avium-intracellular Infection; HIV Infections |
Abbott |
1994-01 | |
| NCT00002336 | COMPLETED | Mycobacterium Avium-intracellular Infection; HIV Infections |
Abbott |
1992-11 | |
| NCT00001030 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE3 | |
| NCT00149084 | UNKNOWN | Helicobacter Infections; Gastritis; Gastric Ulcer; Duodenal Ulcer |
Hamamatsu University |
2003-04 | PHASE3 |
| NCT00001039 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00643227 | COMPLETED | Pneumonia |
Pfizer |
2003-01 | PHASE3 |
| NCT00381147 | COMPLETED | Bronchiolitis Obliterans; Acute Obliterating Bronchiolitis |
Baqiyatallah Medical Sciences University |
PHASE3 | |
| NCT00003617 | UNKNOWN | Gastric Cancer |
Lymphoma Trials Office |
1995-03 | PHASE3 |
| NCT00000971 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
Abbott |
PHASE1 | |
| NCT00281047 | UNKNOWN | Helicobacter Pylori |
Hamamatsu University |
2006-01 | PHASE2; PHASE3 |
| NCT00475527 | WITHDRAWN | Anemia, Iron-Deficiency; Helicobacter Pylori |
Hadassah Medical Organization |
PHASE4 | |
| NCT00000826 | COMPLETED | Bacterial Infections; Mycoses; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00001023 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00154440 | UNKNOWN | Lymphoma; Lymphoma, Non-Hodgkin |
Technische Universität Dresden |
2001-11 | PHASE3 |
| NCT00368342 | COMPLETED | Asthma |
Baqiyatallah Medical Sciences University |
PHASE4 | |
| NCT00197418 | UNKNOWN | Helicobacter Infections; Gastritis; Gastric Ulcer; Duodenal Ulcer |
Hamamatsu University |
2003-08 | PHASE2; PHASE3 |
| NCT00367913 | COMPLETED | Pulmonary Diseases |
British Thoracic Society |
1995-03 | PHASE4 |
| NCT00001058 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00002140 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
Pfizer |
PHASE3 | |
| NCT00354952 | COMPLETED | Healthy Volunteers |
Universiteit Antwerpen |
2002-07 | |
| NCT00002194 | COMPLETED | HIV Infections |
Boehringer Ingelheim |
PHASE1 | |
| NCT00000794 | COMPLETED | Toxoplasmosis, Cerebral; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00002192 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Anderson Clinical Research |
PHASE2 | |
| NCT00403364 | COMPLETED | Helicobacter Pylori Infection |
IRCCS Azienda Ospedaliero-Universitaria di Bologna |
2003-07 | PHASE2; PHASE3 |
| NCT00004689 | COMPLETED | Mycobacterium Avium-intracellulare Infection |
National Jewish Health |
1991-01 | PHASE2 |
| NCT00001047 | COMPLETED | Mycobacterium Avium-intracellulare Infection; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE3 | |
| NCT00002101 | COMPLETED | Mycobacterium Avium-Intracellulare Infection; HIV Infections |
Pharmacia |
PHASE3 | |
| NCT00297674 | COMPLETED | Sepsis; Ventilator Associated Pneumonia |
University of Athens |
2004-06 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-03-20)
Check the
Clarithromycin
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.